Share:
  • Title:How can outcomes be improved in patients with molecularly-defined high-risk AML?
  • Duration: 8:37
  • Plays: 98 views
  • Published: 1 year ago
Download MP3
Download MP4


Simillar Videos

“How I treat” a patient with AML in remission after intensive chemotherapy not proceeding to HSCT▶️ 9:07
“how I Treat” A Patient With Aml In Remission After Intensive Chemotherapy Not Proceeding To Hsct 98 views • 2 weeks ago
In the AML treatment landscape, when is anti-infection and anti-fungal prophylaxis recommended?▶️ 5:29
In The Aml Treatment Landscape, When Is Anti-infection And Anti-fungal Prophylaxis Recommended? 98 views • 1 year ago
How can we improve efficacy of CAR T-cell therapy in AML?▶️ 4:46
How Can We Improve Efficacy Of Car T-cell Therapy In Aml? 98 views • 3 years ago
Should MRD negativity post remission impact treatment decisions in ELN-intermediate risk AML?▶️ 11:54
Should Mrd Negativity Post Remission Impact Treatment Decisions In Eln-intermediate Risk Aml? 98 views • 3 months ago
What exciting updates on maintenance therapy in AML were presented at ASH 2023?▶️ 6:21
What Exciting Updates On Maintenance Therapy In Aml Were Presented At Ash 2023? 98 views • 10 months ago